purevax rcp felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunomodulatorów dla kotów, - koty - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcpch felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunomodulatorów dla kotów, - koty - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
prenessa 4 mg tabletki
krka, d.d., novo mesto - perindoprilum - tabletki - 4 mg
co-prenessa 4 mg/1,25 mg tabletki 4 mg + 1,25 mg tabletki
krka, d.d., novo mesto - tert-butylamini perindoprilum + indapamidum - tabletki - 4 mg + 1,25 mg
co-prenessa 2 mg/0,625 mg tabletki 2 mg + 0,625 mg tabletki
krka, d.d., novo mesto - tert-butylamini perindoprilum + indapamidum - tabletki - 2 mg + 0,625 mg
prenessa 8 mg tabletki
krka, d.d., novo mesto - tert-butylamini perindoprilum - tabletki - 8 mg
kefrenex 25 mg tabletki powlekane
aristo pharma sp. z o.o. - quetiapinum - tabletki powlekane - 25 mg
kefrenex 300 mg tabletki powlekane
aristo pharma sp. z o.o. - quetiapinum - tabletki powlekane - 300 mg
kefrenex 100 mg tabletki powlekane
aristo pharma sp. z o.o. - quetiapinum - tabletki powlekane - 100 mg
kefrenex 200 mg tabletki powlekane
aristo pharma sp. z o.o. - quetiapinum - tabletki powlekane - 200 mg